TRENDS IN APPROVAL OF THERAPEUTIC BIOLOGIC APPROVED BY THE US FOOD AND DRUG ADMINISTRATION (1986-2017)

被引：0
|
作者：
Kim, J. [1 ]
Min, E. [1 ]
Nishikawa, K. [1 ]
Patel, P. [1 ]
Rouzitalab, L. [1 ]
Tomaszewski, D. M. [1 ]
Seoane-Vazquez, E. [1 ]
机构：
[1] Chapman Univ, Irvine, CA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.631
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP40
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [41] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (08) : 1619 - 1632
  • [42] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020
    Kayki-Mutlu, Gizem
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (05) : 839 - 852
  • [43] Three US Food and Drug Administration-approved therapies for chronic GVHD
    Zeiser, Robert
    Lee, Stephanie J.
    BLOOD, 2022, 139 (11) : 1642 - 1645
  • [44] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 867 - 885
  • [45] US Food and Drug Administration-Approved Laboratory Tests After Caronia
    Allen, Timothy Craig
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (11) : 1543 - 1544
  • [46] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 2949 - 2970
  • [47] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Liang, Fei
    Zhang, Sheng
    Wang, Qin
    Li, Wenfeng
    BMC CANCER, 2020, 20 (01)
  • [48] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 1619 - 1632
  • [49] Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
    Tibau, Ariadna
    Molto, Consolacion
    Ocana, Alberto
    Templeton, Arnoud J.
    Del Carpio, Luis P.
    Del Paggio, Joseph C.
    Barnadas, Agusti
    Booth, Christopher M.
    Amir, Eitan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (05): : 486 - 492
  • [50] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Fei Liang
    Sheng Zhang
    Qin Wang
    Wenfeng Li
    BMC Cancer, 20
12345